Go Pro

Ameren (AEE) Financials

Ameren logo
$107.39 -1.45 (-1.33%)
As of 12:47 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Ameren

Annual Income Statements for Ameren

This table shows Ameren's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
630 653 523 815 828 871 990 1,074 1,152 1,182 1,456
Consolidated Net Income / (Loss)
636 659 529 821 834 877 995 1,079 1,157 1,187 1,461
Net Income / (Loss) Continuing Operations
585 659 529 821 834 877 995 1,079 1,157 1,187 1,461
Total Pre-Tax Income
948 1,041 1,105 1,058 1,016 1,032 1,152 1,255 1,340 1,270 1,597
Total Operating Income
1,259 1,322 1,410 1,357 1,267 1,300 1,333 1,515 1,558 1,516 2,026
Total Gross Profit
2,597 2,634 2,783 2,795 2,743 2,858 2,991 3,343 3,467 3,653 4,171
Total Revenue
6,098 6,076 6,174 6,291 5,910 5,794 6,394 7,957 7,500 7,623 8,799
Operating Revenue
6,098 6,076 6,174 6,291 5,910 5,794 6,394 7,957 7,500 7,623 8,799
Total Cost of Revenue
3,501 3,442 3,391 3,496 3,167 2,936 3,403 4,614 4,033 3,970 4,628
Operating Cost of Revenue
3,501 3,442 3,391 3,496 3,167 2,936 3,403 4,614 4,033 3,970 4,628
Total Operating Expenses
1,338 1,312 1,373 1,438 1,476 1,558 1,658 1,828 1,909 2,137 2,145
Depreciation Expense
796 845 896 955 995 1,075 1,146 1,289 1,387 1,590 1,568
Other Operating Expenses / (Income)
473 467 477 483 481 483 512 539 522 547 577
Total Other Income / (Expense), net
-311 -281 -305 -299 -251 -268 -181 -260 -218 -246 -429
Interest Expense
355 382 391 401 381 419 383 486 566 663 776
Other Income / (Expense), net
44 101 86 102 130 151 202 226 348 417 347
Income Tax Expense
363 382 576 237 182 155 157 176 183 83 136
Net Income / (Loss) Attributable to Noncontrolling Interest
6.00 6.00 6.00 6.00 6.00 6.00 5.00 5.00 5.00 5.00 5.00
Basic Earnings per Share
$2.60 $2.69 $2.16 $3.34 $3.37 $3.53 $3.86 $4.16 $4.39 $4.43 $5.38
Weighted Average Basic Shares Outstanding
242.60M 242.60M 242.60M 243.80M 245.60M 247M 256.30M 258.40M 262.80M 266.80M 270.50M
Diluted Earnings per Share
$2.59 $2.68 $2.14 $3.32 $3.35 $3.50 $3.84 $4.14 $4.38 $4.42 $5.35
Weighted Average Diluted Shares Outstanding
243.60M 243.40M 244.20M 245.80M 247.10M 248.70M 257.60M 259.50M 263.40M 267.40M 272.20M
Weighted Average Basic & Diluted Shares Outstanding
244.60M 242.80M 370.21M 372.22M 373.81M 380.93M 385.30M 389.60M 393.87M 397.48M 404.00M
Cash Dividends to Common per Share
$1.66 $1.72 $1.78 $1.85 $1.92 $2.00 $2.20 $2.36 $2.52 $2.68 $2.84

Quarterly Income Statements for Ameren

This table shows Ameren's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
158 261 258 456 207 289 275 640 252 357 314
Consolidated Net Income / (Loss)
159 262 260 457 208 290 277 641 253 358 316
Net Income / (Loss) Continuing Operations
159 262 260 457 208 290 277 641 253 358 316
Total Pre-Tax Income
198 306 299 514 151 340 320 693 244 418 368
Total Operating Income
264 371 361 586 198 430 411 825 360 532 459
Total Gross Profit
751 867 868 1,124 794 941 928 1,404 898 1,081 1,025
Total Revenue
1,618 1,816 1,693 2,173 1,941 2,097 2,221 2,699 1,782 2,176 2,092
Operating Revenue
1,618 1,816 1,693 2,173 1,941 2,097 2,221 2,699 1,782 2,176 2,092
Total Cost of Revenue
867 949 825 1,049 1,147 1,156 1,293 1,295 884 1,095 1,067
Operating Cost of Revenue
867 949 825 1,049 1,147 1,156 1,293 1,295 884 1,095 1,067
Total Operating Expenses
487 496 507 538 596 511 517 579 538 549 566
Depreciation Expense
363 361 376 388 465 367 386 415 400 398 420
Other Operating Expenses / (Income)
124 135 131 150 131 144 131 164 138 151 146
Total Other Income / (Expense), net
-66 -65 -62 -72 -47 -90 -91 -132 -116 -114 -91
Interest Expense
153 154 165 173 171 175 187 208 206 204 209
Other Income / (Expense), net
87 89 103 101 124 85 96 76 90 90 118
Income Tax Expense
39 44 39 57 -57 50 43 52 -9.00 60 52
Net Income / (Loss) Attributable to Noncontrolling Interest
1.00 1.00 2.00 1.00 1.00 1.00 2.00 1.00 1.00 1.00 2.00
Basic Earnings per Share
$0.60 $0.98 $0.97 $1.71 $0.77 $1.07 $1.02 $2.37 $0.92 $1.29 $1.14
Weighted Average Basic Shares Outstanding
262.80M 266.40M 266.70M 266.80M 266.80M 270M 270.30M 270.40M 270.50M 276.50M 276.80M
Diluted Earnings per Share
$0.61 $0.98 $0.97 $1.70 $0.77 $1.07 $1.01 $2.35 $0.92 $1.28 $1.13
Weighted Average Diluted Shares Outstanding
263.40M 266.80M 266.80M 267.30M 267.40M 271.40M 271.60M 272.20M 272.20M 278.40M 278.70M
Weighted Average Basic & Diluted Shares Outstanding
393.87M 394.25M 394.39M 394.50M 397.48M 397.86M 397.99M 398.07M 404.00M 404.33M 404.42M

Annual Cash Flow Statements for Ameren

This table details how cash moves in and out of Ameren's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
287 -299 16 39 69 125 -297 61 56 56 92
Net Cash From Operating Activities
2,031 2,117 2,118 2,170 2,170 1,727 3,252 2,263 2,564 2,763 3,353
Net Cash From Continuing Operating Activities
2,035 2,117 2,118 2,170 2,170 1,727 3,252 2,263 2,564 2,763 3,353
Net Income / (Loss) Continuing Operations
585 659 529 821 834 877 1,943 1,079 1,157 1,187 1,461
Consolidated Net Income / (Loss)
636 659 529 821 834 877 1,943 1,079 1,157 1,187 1,461
Depreciation Expense
777 835 876 938 1,002 1,153 2,394 1,373 1,432 1,524 1,612
Amortization Expense
119 110 98 115 98 22 158 86 84 100 75
Non-Cash Adjustments To Reconcile Net Income
53 -6.00 -17 28 -22 11 -16 49 -12 39 3.00
Changes in Operating Assets and Liabilities, net
501 519 632 268 258 -336 -1,227 -324 -97 -87 202
Net Cash From Investing Activities
-1,976 -2,158 -2,204 -2,336 -2,435 -3,329 -6,887 -3,370 -3,798 -4,456 -4,145
Net Cash From Continuing Investing Activities
-1,951 -2,158 -2,204 -2,336 -2,435 -3,329 -6,887 -3,370 -3,798 -4,456 -4,145
Purchase of Property, Plant & Equipment
-1,917 -2,076 -2,132 -2,286 -2,411 -3,233 -6,926 -3,351 -3,597 -4,319 -4,128
Purchase of Investments
-363 -322 -321 -315 -463 -224 -904 -229 -266 -584 -440
Sale and/or Maturity of Investments
349 304 305 299 467 183 878 216 240 564 416
Other Investing Activities, net
-20 -64 -56 -34 -28 -55 65 -6.00 -175 -117 7.00
Net Cash From Financing Activities
232 -258 102 205 334 1,727 3,338 1,168 1,290 1,749 884
Net Cash From Continuing Financing Activities
232 -258 102 205 334 1,727 3,338 1,168 1,290 1,749 884
Repayment of Debt
-533 -397 -693 -857 -597 -462 -90 -523 -131 -939 -365
Payment of Dividends
-408 -422 -437 -457 -478 -500 -599 -615 -667 -719 -773
Issuance of Debt
1,197 653 1,271 1,464 1,370 2,233 3,293 1,989 1,762 3,142 1,461
Issuance of Common Equity
- 0.00 0.00 74 68 476 308 333 346 273 574
Other Financing Activities, net
-12 -32 -15 -19 -29 -20 452 -16 -20 -8.00 -13
Cash Interest Paid
335 358 370 387 367 383 779 476 546 611 755
Cash Income Taxes Paid
-15 -12 -19 21 13 13 -23 -8.00 -24 -92 -312

Quarterly Cash Flow Statements for Ameren

This table details how cash moves in and out of Ameren's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
26 83 -80 23 4.00 90 80 -21 -15 65 -15
Net Cash From Operating Activities
533 492 -35 897 817 870 2,126 -160 956 421 770
Net Cash From Continuing Operating Activities
533 492 -35 897 817 870 2,126 -160 956 421 770
Net Income / (Loss) Continuing Operations
159 262 19 457 208 569 845 73 253 358 316
Consolidated Net Income / (Loss)
159 262 19 457 208 569 845 73 253 358 316
Depreciation Expense
369 379 16 382 382 776 1,163 -359 413 417 424
Amortization Expense
16 23 3.00 26 27 49 31 -3.00 22 26 27
Non-Cash Adjustments To Reconcile Net Income
-6.00 15 -26 56 -19 -10 -37 29 13 -14 -52
Changes in Operating Assets and Liabilities, net
-5.00 -187 -47 -24 219 -514 124 100 255 -366 55
Net Cash From Investing Activities
-1,142 -906 -172 -1,174 -1,350 -2,097 -3,090 1,065 -1,033 -1,614 -1,092
Net Cash From Continuing Investing Activities
-1,142 -906 -172 -1,174 -1,350 -2,097 -3,090 1,065 -1,033 -1,614 -1,092
Purchase of Property, Plant & Equipment
-1,026 -890 -163 -1,137 -1,290 -2,085 -3,133 1,079 -1,010 -1,574 -1,079
Purchase of Investments
-110 -70 -183 -176 -85 -214 -381 115 -67 -87 -81
Sale and/or Maturity of Investments
104 66 177 171 84 186 353 -98 68 76 82
Other Investing Activities, net
-110 -12 -3.00 -32 -59 16 71 -31 -24 -29 -14
Net Cash From Financing Activities
635 497 127 300 537 1,317 1,044 -926 62 1,258 307
Net Cash From Continuing Financing Activities
635 497 127 300 537 1,317 1,044 -926 62 1,258 307
Repayment of Debt
-21 0.00 37 -514 -75 -637 -361 337 -41 -350 -28
Repurchase of Common Equity
- -5.00 -10 -1.00 - -15 -11 5.00 - -12 -7.00
Payment of Dividends
-167 -179 -179 -180 -180 -318 -323 -65 -193 -209 -208
Issuance of Debt
493 679 268 986 530 2,287 1,727 -1,213 -260 1,831 540
Issuance of Common Equity
318 10 11 9.00 243 13 12 10 539 12 10

Annual Balance Sheets for Ameren

This table presents Ameren's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
23,640 24,699 25,945 27,215 28,933 32,030 35,735 37,904 40,830 44,598 48,476
Total Current Assets
1,917 1,593 1,612 1,533 1,431 1,653 1,968 2,668 2,181 2,264 2,571
Cash & Equivalents
292 9.00 10 16 16 139 8.00 10 25 7.00 13
Accounts Receivable
725 795 838 837 734 749 820 1,100 813 967 1,187
Inventories, net
538 527 522 483 494 521 592 667 733 762 774
Other Current Assets
348 262 242 197 187 244 540 651 504 528 597
Plant, Property, & Equipment, net
18,799 20,113 21,466 22,810 24,376 26,807 29,261 31,262 33,776 36,304 39,313
Total Noncurrent Assets
2,924 2,993 2,867 2,872 3,126 3,159 4,506 3,974 4,873 6,030 6,592
Goodwill
411 411 411 411 411 - 411 411 411 411 411
Employee Benefit Assets
- - - - - 288 756 411 581 757 977
Other Noncurrent Operating Assets
2,513 2,582 2,456 2,461 2,715 2,871 3,339 3,152 3,881 4,862 5,204
Total Liabilities & Shareholders' Equity
23,640 24,699 25,945 27,215 28,933 32,030 35,735 37,904 40,830 44,598 48,476
Total Liabilities
16,552 17,454 18,619 19,442 20,732 22,889 25,906 27,267 29,352 32,355 34,946
Total Current Liabilities
2,093 2,674 2,940 2,687 2,505 2,180 2,826 3,366 3,345 3,413 3,907
Short-Term Debt
696 1,239 1,325 1,177 882 498 1,050 1,410 1,385 1,460 1,616
Accounts Payable
777 805 902 817 874 958 1,095 1,159 1,136 1,059 1,254
Customer Deposits
100 107 108 0.00 0.00 - - 115 176 223 238
Current Deferred & Payable Income Tax Liabilities
43 46 52 - 0.00 0.00 - - - - 0.00
Other Current Liabilities
359 384 454 693 655 549 681 682 501 475 570
Other Current Nonoperating Liabilities
118 93 99 - 94 114 - - 147 196 229
Total Noncurrent Liabilities
14,459 14,780 15,679 16,755 18,227 20,770 23,080 23,901 26,007 28,942 31,039
Long-Term Debt
6,880 6,595 7,094 7,859 8,915 11,078 12,562 13,685 15,121 17,262 18,214
Asset Retirement Reserve & Litigation Obligation
2,523 2,620 5,025 5,264 5,525 5,978 6,605 6,072 6,284 6,719 7,104
Noncurrent Deferred & Payable Income Tax Liabilities
3,945 4,319 2,555 2,666 2,919 3,211 3,499 3,804 4,176 4,474 5,181
Other Noncurrent Operating Liabilities
531 477 460 408 467 503 414 340 426 487 540
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
7,088 7,245 7,326 7,773 8,201 8,938 9,829 10,637 11,478 12,243 13,530
Total Preferred & Common Equity
6,946 7,103 7,184 7,631 8,059 8,938 9,700 10,508 11,349 12,114 13,401
Preferred Stock
0.00 0.00 - 0.00 0.00 0.00 - - - - 0.00
Total Common Equity
6,946 7,103 7,184 7,631 8,059 8,939 9,700 10,508 11,349 12,114 13,401
Common Stock
5,618 5,558 5,542 5,629 5,696 6,182 6,505 6,863 7,219 7,516 8,109
Retained Earnings
1,331 1,568 1,660 2,024 2,380 2,757 3,182 3,646 4,136 4,604 5,292
Accumulated Other Comprehensive Income / (Loss)
-3.00 -23 -18 -22 -17 - 13 -1.00 -6.00 -6.00 0.00
Noncontrolling Interest
- - 142 142 142 - 129 129 129 129 129

Quarterly Balance Sheets for Ameren

This table presents Ameren's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
39,599 40,830 41,306 42,334 43,298 44,598 45,665 46,625 47,416 49,846 51,216
Total Current Assets
2,084 2,181 2,084 2,217 2,257 2,264 2,455 2,474 2,610 2,567 2,644
Cash & Equivalents
8.00 25 85 19 17 7.00 23 11 9.00 13 12
Accounts Receivable
1,022 813 861 983 1,069 871 1,247 1,135 1,285 1,176 1,277
Inventories, net
760 733 679 740 792 762 669 738 804 733 800
Other Current Assets
294 504 459 475 379 528 516 590 512 645 555
Plant, Property, & Equipment, net
32,938 33,776 34,114 34,873 35,720 36,304 37,010 37,816 38,411 40,471 41,372
Total Noncurrent Assets
4,577 4,873 5,108 5,244 5,321 6,030 6,200 6,335 6,395 6,808 7,200
Goodwill
411 411 411 411 411 411 411 411 411 411 411
Employee Benefit Assets
470 581 597 566 581 757 765 734 741 991 973
Other Noncurrent Operating Assets
3,696 3,881 4,100 4,267 4,329 4,862 5,024 5,190 5,243 5,406 5,816
Total Liabilities & Shareholders' Equity
39,599 40,830 41,306 42,334 43,298 44,598 45,665 46,625 47,416 49,846 51,216
Total Liabilities
28,427 29,352 29,734 30,666 31,336 32,355 33,317 34,182 34,507 36,161 37,400
Total Current Liabilities
4,017 3,345 3,505 3,293 3,567 3,413 2,863 3,087 2,805 4,126 4,978
Short-Term Debt
2,189 1,385 2,017 1,490 1,839 1,460 1,269 1,170 932 2,301 2,744
Accounts Payable
955 1,136 647 774 717 1,059 702 882 762 733 998
Customer Deposits
- 176 190 197 205 223 223 240 248 239 248
Current Deferred & Payable Income Tax Liabilities
209 - 0.00 0.00 206 - 0.00 155 215 0.00 0.00
Other Current Liabilities
664 501 651 655 600 475 510 410 465 674 742
Other Current Nonoperating Liabilities
- 147 - 177 - 196 159 230 183 179 246
Total Noncurrent Liabilities
24,410 26,007 26,229 27,373 27,769 28,942 30,454 31,095 31,702 32,035 32,422
Long-Term Debt
13,829 15,121 15,167 16,280 16,422 17,262 18,354 18,811 19,172 19,003 19,064
Asset Retirement Reserve & Litigation Obligation
6,097 6,284 6,372 6,322 6,360 6,719 6,783 6,852 6,933 7,115 7,310
Noncurrent Deferred & Payable Income Tax Liabilities
4,068 4,176 4,251 4,325 4,477 4,474 4,782 4,881 5,081 5,311 5,381
Other Noncurrent Operating Liabilities
416 426 439 446 510 487 535 551 516 606 667
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
11,172 11,478 11,572 11,668 11,962 12,243 12,348 12,443 12,909 13,685 13,816
Total Preferred & Common Equity
11,043 11,349 11,443 11,539 11,833 12,114 12,219 12,314 12,780 13,556 13,687
Preferred Stock
- - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00
Total Common Equity
11,043 11,349 11,443 11,539 11,833 12,114 12,219 12,314 12,780 13,556 13,687
Common Stock
6,903 7,219 7,231 7,249 7,267 7,516 7,527 7,544 7,562 8,117 8,135
Retained Earnings
4,144 4,136 4,219 4,299 4,576 4,604 4,702 4,784 5,232 5,441 5,549
Accumulated Other Comprehensive Income / (Loss)
-4.00 -6.00 -7.00 -9.00 -10 -6.00 -10 -14 -14 -2.00 3.00
Noncontrolling Interest
129 129 129 129 129 129 129 129 129 129 129

Annual Metrics And Ratios for Ameren

This table displays calculated financial ratios and metrics derived from Ameren's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.74% -0.36% 1.61% 1.90% -6.06% -1.96% 10.36% 24.44% -5.74% 1.64% 15.43%
EBITDA Growth
3.53% 7.69% 4.31% 1.70% -0.60% 5.17% 55.64% -21.70% 6.94% 3.95% 14.14%
EBIT Growth
-0.61% 9.21% 5.13% -2.47% -4.25% 3.87% 5.79% 13.42% 9.48% 1.42% 22.76%
NOPAT Growth
1.34% 7.72% -19.34% 56.00% -1.23% 6.22% 4.22% 13.13% 3.28% 5.33% 30.81%
Net Income Growth
7.43% 3.62% -19.73% 55.20% 1.58% 5.16% 13.46% 8.44% 7.23% 2.59% 23.08%
EPS Growth
7.92% 3.47% -20.15% 55.14% 0.90% 4.48% 9.71% 7.81% 5.80% 0.91% 21.04%
Operating Cash Flow Growth
29.78% 4.23% 0.05% 2.46% 0.00% -20.41% 88.30% -30.41% 13.30% 7.76% 21.35%
Free Cash Flow Firm Growth
323.46% -13.32% -97.32% 2,242.59% -358.41% -352.85% -81.11% 62.14% -55.44% -39.93% 67.27%
Invested Capital Growth
4.35% 4.75% 4.43% 6.06% 7.64% 12.20% 15.50% 8.78% 9.88% 10.92% 7.77%
Revenue Q/Q Growth
-1.01% 0.80% 0.70% 0.32% -1.71% 0.21% 3.51% 6.72% -5.40% 4.42% -1.77%
EBITDA Q/Q Growth
1.66% 0.64% 3.22% 56.02% 69.98% -23.71% 112.53% -26.28% -28.72% -29.23% 3.94%
EBIT Q/Q Growth
0.77% 0.14% 5.87% -3.51% 1.90% 2.47% 0.20% 4.44% 1.55% -1.48% 5.70%
NOPAT Q/Q Growth
-0.87% -3.45% -13.40% 20.65% 0.80% 3.21% -1.60% 6.13% -1.63% 3.65% 5.61%
Net Income Q/Q Growth
-2.90% 0.46% -14.81% 18.47% 3.22% 2.45% 1.02% 3.65% -0.43% 4.31% 3.18%
EPS Q/Q Growth
0.00% 0.00% -14.74% 19.00% 3.08% 2.34% 0.52% 3.76% -0.45% 3.76% 2.88%
Operating Cash Flow Q/Q Growth
6.67% 3.37% -3.95% 92.89% -31.85% -43.47% 788.52% -38.15% -47.38% -43.82% 4.32%
Free Cash Flow Firm Q/Q Growth
35.41% 6.48% -97.04% 221.76% -5,691.00% -71.76% 15.85% 30.44% -117.81% 0.96% 53.63%
Invested Capital Q/Q Growth
0.81% 0.52% 0.67% 0.68% 2.04% 4.40% 2.01% 0.82% 3.01% 2.82% 1.17%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
42.59% 43.35% 45.08% 44.43% 46.41% 49.33% 46.78% 42.01% 46.23% 47.92% 47.40%
EBITDA Margin
36.06% 38.97% 40.01% 39.93% 42.25% 45.32% 63.92% 40.22% 45.63% 46.66% 46.14%
Operating Margin
20.65% 21.76% 22.84% 21.57% 21.44% 22.44% 20.85% 19.04% 20.77% 19.89% 23.03%
EBIT Margin
21.37% 23.42% 24.23% 23.19% 23.64% 25.04% 24.01% 21.88% 25.41% 25.36% 26.97%
Profit (Net Income) Margin
10.43% 10.85% 8.57% 13.05% 14.11% 15.14% 15.56% 13.56% 15.43% 15.57% 16.60%
Tax Burden Percent
67.09% 63.30% 47.87% 77.60% 82.09% 84.98% 86.37% 85.98% 86.34% 93.46% 91.48%
Interest Burden Percent
72.76% 73.16% 73.86% 72.52% 72.73% 71.12% 75.05% 72.09% 70.30% 65.70% 67.30%
Effective Tax Rate
38.29% 36.70% 52.13% 22.40% 17.91% 15.02% 13.63% 14.02% 13.66% 6.54% 8.52%
Return on Invested Capital (ROIC)
5.48% 5.65% 4.36% 6.45% 5.97% 5.76% 5.27% 5.33% 5.03% 4.80% 5.73%
ROIC Less NNEP Spread (ROIC-NNEP)
3.52% 3.32% 2.58% 3.81% 3.78% 3.61% 4.01% 3.75% 3.83% 3.50% 3.71%
Return on Net Nonoperating Assets (RNNOA)
3.64% 3.55% 2.91% 4.42% 4.48% 4.47% 5.34% 5.22% 5.43% 5.21% 5.61%
Return on Equity (ROE)
9.12% 9.20% 7.26% 10.87% 10.44% 10.23% 10.60% 10.54% 10.46% 10.01% 11.34%
Cash Return on Invested Capital (CROIC)
1.22% 1.01% 0.03% 0.58% -1.39% -5.74% -9.12% -3.09% -4.39% -5.56% -1.76%
Operating Return on Assets (OROA)
5.67% 5.89% 5.91% 5.49% 4.98% 4.76% 4.53% 4.73% 4.84% 4.53% 5.10%
Return on Assets (ROA)
2.77% 2.73% 2.09% 3.09% 2.97% 2.88% 2.94% 2.93% 2.94% 2.78% 3.14%
Return on Common Equity (ROCE)
8.94% 9.01% 7.12% 10.67% 10.26% 10.15% 10.53% 10.41% 10.34% 9.90% 11.22%
Return on Equity Simple (ROE_SIMPLE)
9.16% 9.28% 7.36% 10.76% 10.35% 9.81% 10.26% 10.27% 10.19% 9.80% 0.00%
Net Operating Profit after Tax (NOPAT)
777 837 675 1,053 1,040 1,105 1,151 1,303 1,345 1,417 1,853
NOPAT Margin
12.74% 13.77% 10.93% 16.74% 17.60% 19.07% 18.01% 16.37% 17.94% 18.59% 21.06%
Net Nonoperating Expense Percent (NNEP)
1.96% 2.32% 1.78% 2.65% 2.18% 2.15% 1.25% 1.57% 1.20% 1.30% 2.01%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 5.06% 4.81% 4.58% 5.56%
Cost of Revenue to Revenue
57.41% 56.65% 54.92% 55.57% 53.59% 50.67% 53.22% 57.99% 53.77% 52.08% 52.60%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
21.94% 21.59% 22.24% 22.86% 24.97% 26.89% 25.93% 22.97% 25.45% 28.03% 24.38%
Earnings before Interest and Taxes (EBIT)
1,303 1,423 1,496 1,459 1,397 1,451 1,535 1,741 1,906 1,933 2,373
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,199 2,368 2,470 2,512 2,497 2,626 4,087 3,200 3,422 3,557 4,060
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.80 2.21 2.53 2.73 3.13 2.95 3.28 3.06 2.41 2.90 2.97
Price to Tangible Book Value (P/TBV)
1.91 2.34 2.68 2.88 3.30 2.95 3.42 3.19 2.50 3.00 3.06
Price to Revenue (P/Rev)
2.04 2.58 2.94 3.31 4.27 4.56 4.97 4.04 3.64 4.61 4.52
Price to Earnings (P/E)
19.79 24.00 34.74 25.52 30.49 30.32 32.10 29.95 23.71 29.75 27.30
Dividend Yield
4.91% 4.05% 3.62% 3.30% 2.84% 2.84% 2.67% 2.83% 3.60% 3.01% 2.84%
Earnings Yield
5.05% 4.17% 2.88% 3.92% 3.28% 3.30% 3.12% 3.34% 4.22% 3.36% 3.66%
Enterprise Value to Invested Capital (EV/IC)
1.36 1.55 1.69 1.78 1.95 1.87 1.94 1.86 1.57 1.74 1.78
Enterprise Value to Revenue (EV/Rev)
3.24 3.87 4.33 4.76 5.95 6.53 7.12 5.95 5.86 7.09 6.78
Enterprise Value to EBITDA (EV/EBITDA)
8.98 9.92 10.82 11.93 14.09 14.41 11.14 14.81 12.83 15.18 14.70
Enterprise Value to EBIT (EV/EBIT)
15.16 16.51 17.86 20.54 25.18 26.08 29.65 27.22 23.04 27.94 25.16
Enterprise Value to NOPAT (EV/NOPAT)
25.43 28.08 39.58 28.46 33.82 34.26 39.53 36.38 32.65 38.12 32.21
Enterprise Value to Operating Cash Flow (EV/OCF)
9.73 11.10 12.62 13.81 16.21 21.91 14.00 20.94 17.13 19.55 17.80
Enterprise Value to Free Cash Flow (EV/FCFF)
114.24 156.76 6,657.06 318.69 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.07 1.08 1.15 1.16 1.19 1.30 1.38 1.42 1.44 1.53 1.47
Long-Term Debt to Equity
0.97 0.91 0.97 1.01 1.09 1.24 1.28 1.29 1.32 1.41 1.35
Financial Leverage
1.03 1.07 1.13 1.16 1.18 1.24 1.33 1.39 1.42 1.49 1.51
Leverage Ratio
3.29 3.37 3.48 3.52 3.52 3.56 3.61 3.60 3.56 3.60 3.61
Compound Leverage Factor
2.40 2.47 2.57 2.55 2.56 2.53 2.71 2.59 2.50 2.37 2.43
Debt to Total Capital
51.66% 51.95% 53.47% 53.76% 54.43% 56.43% 58.07% 58.66% 58.98% 60.46% 59.44%
Short-Term Debt to Total Capital
4.75% 8.22% 8.42% 7.00% 4.90% 2.43% 4.48% 5.48% 4.95% 4.72% 4.84%
Long-Term Debt to Total Capital
46.92% 43.74% 45.06% 46.75% 49.53% 54.00% 53.59% 53.18% 54.03% 55.75% 54.60%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.90% 0.84% 0.79% 0.00% 0.55% 0.50% 0.46% 0.42% 0.39%
Common Equity to Total Capital
47.37% 47.11% 45.63% 45.40% 44.78% 43.58% 41.38% 40.84% 40.56% 39.12% 40.17%
Debt to EBITDA
3.45 3.31 3.41 3.60 3.92 4.41 3.33 4.72 4.82 5.26 4.88
Net Debt to EBITDA
3.31 3.30 3.40 3.59 3.92 4.36 3.33 4.71 4.82 5.26 4.88
Long-Term Debt to EBITDA
3.13 2.79 2.87 3.13 3.57 4.22 3.07 4.28 4.42 4.85 4.49
Debt to NOPAT
9.75 9.36 12.47 8.58 9.42 10.48 11.82 11.59 12.27 13.21 10.70
Net Debt to NOPAT
9.38 9.35 12.46 8.57 9.40 10.35 11.82 11.58 12.25 13.21 10.69
Long-Term Debt to NOPAT
8.86 7.88 10.51 7.46 8.57 10.03 10.91 10.51 11.24 12.18 9.83
Altman Z-Score
0.96 1.01 1.04 1.10 1.17 1.12 1.15 1.18 1.00 1.08 1.15
Noncontrolling Interest Sharing Ratio
2.04% 1.98% 1.95% 1.88% 1.78% 0.82% 0.68% 1.26% 1.17% 1.09% 1.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.92 0.60 0.55 0.57 0.57 0.76 0.70 0.79 0.65 0.66 0.66
Quick Ratio
0.49 0.30 0.29 0.32 0.30 0.41 0.29 0.33 0.25 0.26 0.31
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
173 150 4.01 94 -243 -1,100 -1,993 -754 -1,173 -1,641 -569
Operating Cash Flow to CapEx
105.95% 101.98% 99.34% 94.93% 90.00% 53.42% 46.95% 67.53% 71.28% 63.97% 81.23%
Free Cash Flow to Firm to Interest Expense
0.49 0.39 0.01 0.23 -0.64 -2.63 -5.20 -1.55 -2.07 -2.48 -0.73
Operating Cash Flow to Interest Expense
5.72 5.54 5.42 5.41 5.70 4.12 8.49 4.66 4.53 4.17 4.32
Operating Cash Flow Less CapEx to Interest Expense
0.32 0.11 -0.04 -0.29 -0.63 -3.59 -9.59 -2.24 -1.83 -2.35 -1.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.27 0.25 0.24 0.24 0.21 0.19 0.19 0.22 0.19 0.18 0.19
Accounts Receivable Turnover
8.16 7.99 7.56 7.51 7.52 7.81 8.15 8.29 7.84 9.05 8.17
Inventory Turnover
6.59 6.46 6.47 6.96 6.48 5.79 6.12 7.33 5.76 5.31 6.03
Fixed Asset Turnover
0.34 0.31 0.30 0.28 0.25 0.23 0.23 0.26 0.23 0.22 0.23
Accounts Payable Turnover
4.71 4.35 3.97 4.07 3.75 3.21 3.32 4.09 3.51 3.62 4.00
Days Sales Outstanding (DSO)
44.71 45.66 48.27 48.59 48.51 46.71 44.78 44.04 46.55 40.32 44.68
Days Inventory Outstanding (DIO)
55.36 56.47 56.46 52.46 56.30 63.09 59.69 49.80 63.35 68.72 60.57
Days Payable Outstanding (DPO)
77.57 83.88 91.87 89.74 97.44 113.88 110.10 89.15 103.85 100.90 91.21
Cash Conversion Cycle (CCC)
22.51 18.24 12.86 11.32 7.37 -4.07 -5.63 4.68 6.05 8.14 14.04
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
14,476 15,163 15,834 16,793 18,076 20,281 23,425 25,482 28,000 31,058 33,576
Invested Capital Turnover
0.43 0.41 0.40 0.39 0.34 0.30 0.29 0.33 0.28 0.26 0.27
Increase / (Decrease) in Invested Capital
604 687 671 959 1,283 2,205 3,144 2,057 2,518 3,058 2,422
Enterprise Value (EV)
19,754 23,497 26,719 29,964 35,172 37,844 45,512 47,383 43,920 54,010 59,697
Market Capitalization
12,470 15,672 18,168 20,802 25,249 26,407 31,779 32,169 27,310 35,166 39,751
Book Value per Share
$18.76 $19.19 $19.41 $20.52 $21.57 $23.85 $25.18 $27.22 $29.06 $30.71 $33.66
Tangible Book Value per Share
$17.65 $18.08 $18.30 $19.42 $20.47 $23.85 $24.12 $26.15 $28.01 $29.67 $32.63
Total Capital
14,664 15,079 15,745 16,809 17,998 20,514 23,441 25,732 27,984 30,965 33,360
Total Debt
7,576 7,834 8,419 9,036 9,797 11,576 13,612 15,095 16,506 18,722 19,830
Total Long-Term Debt
6,880 6,595 7,094 7,859 8,915 11,078 12,562 13,685 15,121 17,262 18,214
Net Debt
7,284 7,825 8,409 9,020 9,781 11,437 13,604 15,085 16,481 18,715 19,817
Capital Expenditures (CapEx)
1,917 2,076 2,132 2,286 2,411 3,233 6,926 3,351 3,597 4,319 4,128
Debt-free, Cash-free Net Working Capital (DFCFNWC)
228 149 -13 7.00 -208 -168 184 702 196 304 267
Debt-free Net Working Capital (DFNWC)
520 158 -3.00 23 -192 -29 192 712 221 311 280
Net Working Capital (NWC)
-176 -1,081 -1,328 -1,154 -1,074 -527 -858 -698 -1,164 -1,149 -1,336
Net Nonoperating Expense (NNE)
141 178 146 232 206 228 156 224 188 230 392
Net Nonoperating Obligations (NNO)
7,388 7,918 8,508 9,020 9,875 11,343 13,596 14,845 16,522 18,815 20,046
Total Depreciation and Amortization (D&A)
896 945 974 1,053 1,100 1,175 2,552 1,459 1,516 1,624 1,687
Debt-free, Cash-free Net Working Capital to Revenue
3.74% 2.45% -0.21% 0.11% -3.52% -2.90% 2.88% 8.82% 2.61% 3.99% 3.03%
Debt-free Net Working Capital to Revenue
8.53% 2.60% -0.05% 0.37% -3.25% -0.50% 3.00% 8.95% 2.95% 4.08% 3.18%
Net Working Capital to Revenue
-2.89% -17.79% -21.51% -18.34% -18.17% -9.10% -13.42% -8.77% -15.52% -15.07% -15.18%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.60 $2.69 $2.16 $3.34 $3.37 $3.53 $3.86 $4.16 $4.39 $4.43 $5.38
Adjusted Weighted Average Basic Shares Outstanding
242.60M 242.60M 242.60M 243.80M 245.60M 247M 256.30M 258.40M 262.80M 266.80M 270.50M
Adjusted Diluted Earnings per Share
$2.59 $2.68 $2.14 $3.32 $3.35 $3.50 $3.84 $4.14 $4.38 $4.42 $5.35
Adjusted Weighted Average Diluted Shares Outstanding
243.60M 243.40M 244.20M 245.80M 247.10M 248.70M 257.60M 259.50M 263.40M 267.40M 272.20M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
370.21M 370.21M 370.21M 372.22M 373.81M 380.93M 385.30M 389.60M 393.87M 397.48M 404.00M
Normalized Net Operating Profit after Tax (NOPAT)
819 837 987 1,053 1,040 1,105 1,151 1,303 1,345 1,417 1,853
Normalized NOPAT Margin
13.44% 13.77% 15.99% 16.74% 17.60% 19.07% 18.01% 16.37% 17.94% 18.59% 21.06%
Pre Tax Income Margin
15.55% 17.13% 17.90% 16.82% 17.19% 17.81% 18.02% 15.77% 17.87% 16.66% 18.15%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.67 3.73 3.83 3.64 3.67 3.46 4.01 3.58 3.37 2.92 3.06
NOPAT to Interest Expense
2.19 2.19 1.73 2.63 2.73 2.64 3.01 2.68 2.38 2.14 2.39
EBIT Less CapEx to Interest Expense
-1.73 -1.71 -1.63 -2.06 -2.66 -4.25 -14.08 -3.31 -2.99 -3.60 -2.26
NOPAT Less CapEx to Interest Expense
-3.21 -3.24 -3.73 -3.07 -3.60 -5.08 -15.08 -4.21 -3.98 -4.38 -2.93
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
64.15% 64.04% 82.61% 55.66% 57.31% 57.01% 60.20% 57.00% 57.65% 60.57% 52.91%
Augmented Payout Ratio
66.04% 73.14% 87.15% 55.66% 57.31% 57.01% 61.51% 57.00% 57.65% 60.57% 52.91%

Quarterly Metrics And Ratios for Ameren

This table displays calculated financial ratios and metrics derived from Ameren's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - - - - - 404,000,722.00 404,327,823.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 404,000,722.00 404,327,823.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.88 0.78
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-20.92% -11.93% -3.81% 5.49% 19.96% 15.47% 31.19% 24.21% -8.19% 3.77% -5.81%
EBITDA Growth
4.84% 55.81% -67.97% 190.45% -0.68% 8.47% 95.74% -50.78% 21.07% -20.52% 103.56%
EBIT Growth
9.01% 7.23% 12.90% -3.92% -8.26% 11.96% 9.27% 31.15% 39.75% 20.78% 13.81%
NOPAT Growth
-10.07% 3.14% 10.58% -3.29% 28.65% 15.46% 13.33% 46.46% 36.86% 24.23% 10.78%
Net Income Growth
-3.05% -1.13% 8.79% -7.49% 30.82% 10.69% 6.54% 40.26% 21.63% 23.45% 14.08%
EPS Growth
-3.17% -2.00% 7.78% -9.09% 26.23% 9.18% 4.12% 38.24% 19.48% 19.63% 11.88%
Operating Cash Flow Growth
-19.73% 118.55% -102.06% 660.63% 53.28% -12.40% 281.69% -117.84% 17.01% -51.61% 82.03%
Free Cash Flow Firm Growth
-26.62% -13.42% -27.32% -83.07% -20.78% -46.27% -9.57% 11.39% 28.89% 15.54% -4.82%
Invested Capital Growth
9.88% 9.20% 10.33% 11.13% 10.92% 11.98% 10.30% 9.87% 7.77% 9.49% 9.85%
Revenue Q/Q Growth
-21.46% 12.24% -6.77% 28.35% -10.68% 8.04% 5.91% 21.52% -33.98% 22.11% -3.86%
EBITDA Q/Q Growth
95.23% -43.27% -61.30% 126.71% -33.24% 27.91% 81.93% -68.31% 64.19% 20.34% -3.47%
EBIT Q/Q Growth
-50.91% 31.05% 0.87% 48.06% -53.13% 59.94% -1.55% 77.71% -50.06% 38.22% -7.23%
NOPAT Q/Q Growth
-60.65% 49.84% -1.18% 65.97% -47.65% 34.47% -3.00% 114.49% -51.08% 22.06% -13.50%
Net Income Q/Q Growth
-67.81% 64.78% -0.76% 75.77% -54.49% 39.42% -4.48% 131.41% -60.53% 41.50% -11.73%
EPS Q/Q Growth
-67.38% 60.66% -1.02% 75.26% -54.71% 38.96% -5.61% 132.67% -60.85% 39.13% -11.72%
Operating Cash Flow Q/Q Growth
433.13% -63.53% -103.23% 2,662.86% -8.92% -47.25% 393.27% -107.53% 697.50% -55.96% 82.90%
Free Cash Flow Firm Q/Q Growth
-68.66% 13.00% -17.05% -1.91% -11.28% -10.20% 12.32% 17.59% 7.63% -26.54% -8.81%
Invested Capital Q/Q Growth
3.01% 2.01% 3.23% 2.06% 2.82% 3.38% 1.67% 1.67% 1.17% 4.70% 2.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
46.42% 47.74% 51.27% 51.73% 40.91% 44.87% 41.78% 52.02% 50.39% 49.68% 49.00%
EBITDA Margin
45.49% 68.72% 28.53% 50.39% 37.66% 44.59% 76.59% 19.97% 49.66% 48.94% 49.14%
Operating Margin
16.32% 20.43% 21.32% 26.97% 10.20% 20.51% 18.51% 30.57% 20.20% 24.45% 21.94%
EBIT Margin
21.69% 25.33% 27.41% 31.62% 16.59% 24.56% 22.83% 33.38% 25.25% 28.58% 27.58%
Profit (Net Income) Margin
9.83% 14.43% 15.36% 21.03% 10.72% 13.83% 12.47% 23.75% 14.20% 16.45% 15.11%
Tax Burden Percent
80.30% 85.62% 86.96% 88.91% 137.75% 85.29% 86.56% 92.50% 103.69% 85.65% 85.87%
Interest Burden Percent
56.41% 66.52% 64.44% 74.82% 46.89% 66.02% 63.12% 76.91% 54.22% 67.20% 63.78%
Effective Tax Rate
19.70% 14.38% 13.04% 11.09% -37.75% 14.71% 13.44% 7.50% -3.69% 14.35% 14.13%
Return on Invested Capital (ROIC)
3.67% 4.62% 4.72% 6.10% 3.63% 4.55% 4.34% 7.99% 5.69% 5.53% 4.81%
ROIC Less NNEP Spread (ROIC-NNEP)
3.34% 4.28% 4.41% 5.73% 3.26% 4.13% 3.93% 7.36% 5.08% 5.05% 4.44%
Return on Net Nonoperating Assets (RNNOA)
4.73% 6.26% 6.65% 8.48% 4.86% 6.37% 6.21% 11.39% 7.67% 8.00% 7.15%
Return on Equity (ROE)
8.41% 10.88% 11.37% 14.58% 8.49% 10.92% 10.55% 19.39% 13.37% 13.53% 11.96%
Cash Return on Invested Capital (CROIC)
-4.39% -3.86% -4.91% -5.77% -5.56% -6.48% -4.94% -3.87% -1.76% -3.29% -3.61%
Operating Return on Assets (OROA)
4.13% 4.63% 4.85% 5.57% 2.96% 4.46% 4.33% 6.59% 4.77% 5.31% 4.93%
Return on Assets (ROA)
1.87% 2.64% 2.72% 3.70% 1.91% 2.51% 2.36% 4.69% 2.68% 3.06% 2.70%
Return on Common Equity (ROCE)
8.31% 10.75% 11.24% 14.42% 8.39% 10.80% 10.44% 19.18% 13.24% 13.40% 11.84%
Return on Equity Simple (ROE_SIMPLE)
0.00% 10.08% 10.18% 9.62% 0.00% 9.94% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
212 318 314 521 273 367 356 763 373 456 394
NOPAT Margin
13.10% 17.49% 18.54% 23.98% 14.05% 17.49% 16.02% 28.27% 20.95% 20.94% 18.84%
Net Nonoperating Expense Percent (NNEP)
0.34% 0.34% 0.32% 0.37% 0.37% 0.42% 0.41% 0.63% 0.62% 0.47% 0.37%
Return On Investment Capital (ROIC_SIMPLE)
0.76% - - - 0.88% 1.15% 1.10% 2.31% 1.12% 1.30% 1.11%
Cost of Revenue to Revenue
53.58% 52.26% 48.73% 48.27% 59.09% 55.13% 58.22% 47.98% 49.61% 50.32% 51.00%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
30.10% 27.31% 29.95% 24.76% 30.71% 24.37% 23.28% 21.45% 30.19% 25.23% 27.06%
Earnings before Interest and Taxes (EBIT)
351 460 464 687 322 515 507 901 450 622 577
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
736 1,248 483 1,095 731 935 1,701 539 885 1,065 1,028
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.41 2.52 2.43 2.92 2.90 3.27 3.10 3.25 2.97 3.28 2.30
Price to Tangible Book Value (P/TBV)
2.50 2.62 2.52 3.02 3.00 3.38 3.21 3.36 3.06 3.38 2.37
Price to Revenue (P/Rev)
3.64 3.98 3.90 4.73 4.61 5.05 4.53 4.64 4.52 5.00 3.60
Price to Earnings (P/E)
23.71 25.12 23.96 30.44 29.75 32.98 31.14 29.44 27.30 29.14 20.16
Dividend Yield
3.60% 3.49% 3.66% 3.02% 3.01% 2.71% 2.87% 2.68% 2.84% 2.62% 2.58%
Earnings Yield
4.22% 3.98% 4.17% 3.28% 3.36% 3.03% 3.21% 3.40% 3.66% 3.43% 4.96%
Enterprise Value to Invested Capital (EV/IC)
1.57 1.61 1.55 1.75 1.74 1.86 1.79 1.86 1.78 1.87 1.49
Enterprise Value to Revenue (EV/Rev)
5.86 6.35 6.39 7.24 7.09 7.55 6.92 6.90 6.78 7.41 6.11
Enterprise Value to EBITDA (EV/EBITDA)
12.83 8.64 10.66 10.52 15.18 16.43 13.07 15.81 14.70 17.39 12.40
Enterprise Value to EBIT (EV/EBIT)
23.04 23.79 23.07 26.95 27.94 30.00 28.71 27.51 25.16 26.54 20.95
Enterprise Value to NOPAT (EV/NOPAT)
32.65 34.01 33.15 38.67 38.12 40.64 38.59 35.20 32.21 33.89 26.98
Enterprise Value to Operating Cash Flow (EV/OCF)
17.13 8.24 11.89 10.75 19.55 22.07 13.65 19.22 17.80 22.67 16.43
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.44 1.49 1.52 1.53 1.53 1.59 1.61 1.56 1.47 1.56 1.58
Long-Term Debt to Equity
1.32 1.31 1.40 1.37 1.41 1.49 1.51 1.49 1.35 1.39 1.38
Financial Leverage
1.42 1.46 1.51 1.48 1.49 1.54 1.58 1.55 1.51 1.58 1.61
Leverage Ratio
3.56 3.56 3.61 3.58 3.60 3.64 3.69 3.65 3.61 3.67 3.73
Compound Leverage Factor
2.01 2.37 2.33 2.68 1.69 2.40 2.33 2.81 1.96 2.47 2.38
Debt to Total Capital
58.98% 59.76% 60.36% 60.42% 60.46% 61.38% 61.62% 60.90% 59.44% 60.89% 61.22%
Short-Term Debt to Total Capital
4.95% 7.01% 5.06% 6.08% 4.72% 3.97% 3.61% 2.82% 4.84% 6.58% 7.70%
Long-Term Debt to Total Capital
54.03% 52.74% 55.30% 54.34% 55.75% 57.41% 58.02% 58.07% 54.60% 54.31% 53.51%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.46% 0.45% 0.44% 0.43% 0.42% 0.40% 0.40% 0.39% 0.39% 0.37% 0.36%
Common Equity to Total Capital
40.56% 39.79% 39.20% 39.15% 39.12% 38.22% 37.98% 38.71% 40.17% 38.74% 38.42%
Debt to EBITDA
4.82 3.22 4.12 3.63 5.26 5.41 4.48 5.15 4.88 5.63 5.06
Net Debt to EBITDA
4.82 3.21 4.12 3.63 5.26 5.40 4.48 5.14 4.88 5.63 5.06
Long-Term Debt to EBITDA
4.42 2.84 3.78 3.27 4.85 5.06 4.22 4.91 4.49 5.02 4.43
Debt to NOPAT
12.27 12.68 12.83 13.36 13.21 13.37 13.22 11.46 10.70 10.97 11.01
Net Debt to NOPAT
12.25 12.62 12.82 13.35 13.21 13.36 13.22 11.45 10.69 10.96 11.01
Long-Term Debt to NOPAT
11.24 11.19 11.76 12.01 12.18 12.51 12.45 10.92 9.83 9.78 9.63
Altman Z-Score
0.88 0.90 0.87 0.99 0.96 1.06 1.02 1.12 1.01 1.07 0.81
Noncontrolling Interest Sharing Ratio
1.17% 1.16% 1.15% 1.12% 1.09% 1.08% 1.07% 1.04% 1.00% 0.99% 0.98%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.65 0.59 0.67 0.63 0.66 0.86 0.80 0.93 0.66 0.62 0.53
Quick Ratio
0.25 0.27 0.30 0.30 0.26 0.44 0.37 0.46 0.31 0.29 0.26
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-2,306 -2,098 -2,456 -2,503 -2,785 -3,069 -2,691 -2,218 -2,049 -2,592 -2,821
Operating Cash Flow to CapEx
51.95% 62.70% -21.47% 78.89% 63.33% 40.51% 67.86% 0.00% 94.65% 26.75% 71.36%
Free Cash Flow to Firm to Interest Expense
-15.07 -13.63 -14.89 -14.47 -16.29 -17.54 -14.39 -10.66 -9.95 -12.71 -13.50
Operating Cash Flow to Interest Expense
3.48 7.04 -0.21 5.19 4.78 2.46 11.37 -0.77 4.64 2.06 3.68
Operating Cash Flow Less CapEx to Interest Expense
-3.22 -4.19 -1.20 -1.39 -2.77 -3.62 -5.39 4.42 -0.26 -5.65 -1.48
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.19 0.18 0.18 0.18 0.18 0.18 0.19 0.20 0.19 0.19 0.18
Accounts Receivable Turnover
7.84 7.85 7.54 6.98 9.05 7.50 7.96 7.61 8.17 7.33 7.25
Inventory Turnover
5.76 5.68 4.92 4.76 5.31 6.20 6.29 6.13 6.03 6.52 5.65
Fixed Asset Turnover
0.23 0.22 0.21 0.21 0.22 0.22 0.23 0.24 0.23 0.23 0.22
Accounts Payable Turnover
3.51 5.67 4.78 4.41 3.62 6.19 5.61 6.61 4.00 6.37 4.62
Days Sales Outstanding (DSO)
46.55 46.47 48.40 52.28 40.32 48.67 45.84 47.96 44.68 49.81 50.31
Days Inventory Outstanding (DIO)
63.35 64.25 74.16 76.76 68.72 58.90 58.07 59.55 60.57 56.02 64.66
Days Payable Outstanding (DPO)
103.85 64.35 76.30 82.69 100.90 58.94 65.06 55.19 91.21 57.34 79.04
Cash Conversion Cycle (CCC)
6.05 46.37 46.25 46.34 8.14 48.63 38.85 52.32 14.04 48.49 35.94
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
28,000 28,671 29,596 30,206 31,058 32,107 32,643 33,187 33,576 35,155 35,858
Invested Capital Turnover
0.28 0.26 0.25 0.25 0.26 0.26 0.27 0.28 0.27 0.26 0.26
Increase / (Decrease) in Invested Capital
2,518 2,416 2,770 3,024 3,058 3,436 3,047 2,981 2,422 3,048 3,215
Enterprise Value (EV)
43,920 46,085 45,915 52,867 54,010 59,636 58,309 61,766 59,697 65,828 53,429
Market Capitalization
27,310 28,857 28,035 34,494 35,166 39,907 38,210 41,542 39,751 44,408 31,504
Book Value per Share
$29.06 $29.05 $29.27 $30.00 $30.71 $30.74 $30.95 $32.11 $33.66 $33.55 $33.85
Tangible Book Value per Share
$28.01 $28.01 $28.23 $28.96 $29.67 $29.71 $29.92 $31.08 $32.63 $32.54 $32.83
Total Capital
27,984 28,756 29,438 30,223 30,965 31,971 32,424 33,013 33,360 34,989 35,624
Total Debt
16,506 17,184 17,770 18,261 18,722 19,623 19,981 20,104 19,830 21,304 21,808
Total Long-Term Debt
15,121 15,167 16,280 16,422 17,262 18,354 18,811 19,172 18,214 19,003 19,064
Net Debt
16,481 17,099 17,751 18,244 18,715 19,600 19,970 20,095 19,817 21,291 21,796
Capital Expenditures (CapEx)
1,026 1,729 163 1,137 1,290 1,064 3,133 -1,079 1,010 1,574 1,079
Debt-free, Cash-free Net Working Capital (DFCFNWC)
196 511 395 512 304 838 546 728 267 729 398
Debt-free Net Working Capital (DFNWC)
221 596 414 529 311 861 557 737 280 742 410
Net Working Capital (NWC)
-1,164 -1,421 -1,076 -1,310 -1,149 -408 -613 -195 -1,336 -1,559 -2,334
Net Nonoperating Expense (NNE)
53 56 54 64 65 77 79 122 120 98 78
Net Nonoperating Obligations (NNO)
16,522 17,099 17,928 18,244 18,815 19,759 20,200 20,278 20,046 21,470 22,042
Total Depreciation and Amortization (D&A)
385 788 19 408 409 420 1,194 -362 435 443 451
Debt-free, Cash-free Net Working Capital to Revenue
2.61% 7.04% 5.50% 7.01% 3.99% 10.60% 6.48% 8.13% 3.03% 8.21% 4.55%
Debt-free Net Working Capital to Revenue
2.95% 8.22% 5.76% 7.25% 4.08% 10.89% 6.61% 8.23% 3.18% 8.36% 4.69%
Net Working Capital to Revenue
-15.52% -19.59% -14.97% -17.95% -15.07% -5.16% -7.27% -2.18% -15.18% -17.56% -26.68%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.60 $0.98 $0.97 $1.71 $0.77 $1.07 $1.02 $2.37 $0.92 $1.29 $1.14
Adjusted Weighted Average Basic Shares Outstanding
262.80M 266.40M 266.70M 266.80M 266.80M 270M 270.30M 270.40M 270.50M 276.50M 276.80M
Adjusted Diluted Earnings per Share
$0.61 $0.98 $0.97 $1.70 $0.77 $1.07 $1.01 $2.35 $0.92 $1.28 $1.13
Adjusted Weighted Average Diluted Shares Outstanding
263.40M 266.80M 266.80M 267.30M 267.40M 271.40M 271.60M 272.20M 272.20M 278.40M 278.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
393.87M 394.25M 394.39M 394.50M 397.48M 397.86M 397.99M 398.07M 404.00M 404.33M 404.42M
Normalized Net Operating Profit after Tax (NOPAT)
212 318 314 521 139 367 356 763 252 456 394
Normalized NOPAT Margin
13.10% 17.49% 18.54% 23.98% 7.14% 17.49% 16.02% 28.27% 14.14% 20.94% 18.84%
Pre Tax Income Margin
12.24% 16.85% 17.66% 23.65% 7.78% 16.21% 14.41% 25.68% 13.69% 19.21% 17.59%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.29 2.99 2.81 3.97 1.88 2.94 2.71 4.33 2.18 3.05 2.76
NOPAT to Interest Expense
1.39 2.06 1.90 3.01 1.60 2.10 1.90 3.67 1.81 2.23 1.89
EBIT Less CapEx to Interest Expense
-4.41 -8.24 1.82 -2.60 -5.66 -3.14 -14.04 9.52 -2.72 -4.67 -2.40
NOPAT Less CapEx to Interest Expense
-5.32 -9.16 0.91 -3.56 -5.95 -3.98 -14.85 8.86 -3.09 -5.48 -3.28
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
57.65% 63.69% 63.40% 66.87% 60.57% 60.25% 71.02% 53.67% 52.91% 43.43% 51.21%
Augmented Payout Ratio
57.65% 63.95% 63.40% 67.49% 60.57% 60.25% 71.02% 53.67% 52.91% 43.43% 51.21%

Financials Breakdown Chart

Key Financial Trends

Ameren’s latest quarter shows solid earnings and operating cash flow, but the company remains very capital-intensive and balance-sheet leverage is still high. For Q1 2026, Ameren reported revenue of $2.18 billion, up from $1.78 billion in Q4 2025 and slightly above $2.10 billion in Q1 2025. Net income attributable to common shareholders came in at $357 million, or $1.28 per diluted share, compared with $252 million and $0.92 per diluted share in the prior quarter and $289 million / $1.07 a year ago.

Profitability improved sharply versus the immediately preceding quarter. Gross profit rose to $1.08 billion from $898 million in Q4 2025, while operating income climbed to $532 million from $360 million. That said, the quarter was still constrained by a meaningful $204 million interest expense burden, which keeps pre-tax earnings below operating profit.

Cash generation was healthy in Q1 2026. Ameren produced $421 million of operating cash flow, up from $356 million a year earlier and well below the stronger Q4 seasonal level of $956 million. The company spent $1.57 billion on capital investments, highlighting that this utility continues to reinvest heavily in its rate base and infrastructure.

The balance sheet reflects that capital-intensive profile. As of March 31, 2026, Ameren had $49.85 billion in total assets against $36.16 billion in total liabilities. Long-term debt stood at $19.00 billion and short-term debt at $2.30 billion. Cash was only $13 million, so liquidity is minimal even though the company has access to financing markets.

Compared with the last several years, Ameren has grown steadily, but leverage and capital spending have also risen. Revenue in Q1 2026 was above Q1 2025’s $2.10 billion and Q1 2024’s $1.82 billion. Equity also expanded to $13.56 billion from $12.22 billion in Q1 2025 and $10.61 billion in Q1 2023, mostly reflecting ongoing investment and retained earnings growth.

  • Revenue growth remains intact: Q1 2026 revenue of $2.18 billion exceeded both Q1 2025 and Q1 2024 levels.
  • Earnings improved year over year: diluted EPS rose to $1.28 from $1.07 in Q1 2025.
  • Operating income strengthened: Q1 2026 operating income of $532 million was well above $430 million in Q1 2025.
  • Operating cash flow was solid: the company generated $421 million from operations in Q1 2026.
  • Equity base has increased over time: total common equity reached $13.56 billion, up from $12.22 billion a year earlier.
  • Quarterly results are seasonal: Q4 periods tend to show much stronger cash flow and earnings than first quarters.
  • Balance-sheet size continues to expand: assets rose to $49.85 billion, consistent with a utility investing heavily in infrastructure.
  • Leverage remains elevated: combined short-term and long-term debt was about $21.3 billion in Q1 2026.
  • Cash on hand is very low: only $13 million in cash and equivalents leaves little cushion.
  • Capital spending is large: Q1 2026 capex of $1.57 billion continues to consume most operating cash flow and requires ongoing financing.

Bottom line: Ameren continues to look like a classic regulated utility story — modest but steady revenue growth, decent earnings, and strong ongoing investment. The key tradeoff for investors is that the business depends on heavy borrowing and continuous capital deployment, so the shares will likely remain sensitive to interest rates and financing conditions.

08/10/26 11:59 AM ETAI Generated. May Contain Errors.

Ameren Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Ameren's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Ameren's net income appears to be on an upward trend, with a most recent value of $1.46 billion in 2025, rising from $636 million in 2015. The previous period was $1.19 billion in 2024. Check out Ameren's forecast to explore projected trends and price targets.

Ameren's total operating income in 2025 was $2.03 billion, based on the following breakdown:
  • Total Gross Profit: $4.17 billion
  • Total Operating Expenses: $2.15 billion

Over the last 10 years, Ameren's total revenue changed from $6.10 billion in 2015 to $8.80 billion in 2025, a change of 44.3%.

Ameren's total liabilities were at $34.95 billion at the end of 2025, a 8.0% increase from 2024, and a 111.1% increase since 2015.

In the past 10 years, Ameren's cash and equivalents has ranged from $7 million in 2024 to $292 million in 2015, and is currently $13 million as of their latest financial filing in 2025.

Over the last 10 years, Ameren's book value per share changed from 18.76 in 2015 to 33.66 in 2025, a change of 79.4%.



Financial statements for NYSE:AEE last updated on 8/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners